Literature DB >> 21279492

Uptake of F-18 FDG and ultrasound analysis of carotid plaque.

Yun-Seok Choi1, Ho-Joong Youn, Woo-Baek Chung, Hui-Jeong Hwang, Dong-Hyeon Lee, Chul-Soo Park, Jae-Beom Lee, Pum-Joon Kim, Wook-Sung Chung, Man-Young Lee, Kie-Bae Seung, Yong-Ahn Chung.   

Abstract

OBJECTIVES: To elucidate the relation between the echolucent plaque on carotid ultrasound and acute inflammation on F-18 FDG carotid PET/CT.
METHODS: Thirty nine patients (M:F ratio = 23:16, mean age = 63 ± 11 years) that underwent coronary angiography and carotid ultrasound were divided into three groups-echolucent plaque (n = 22), calcified (n = 10), and no plaque(n = 7). All the patients underwent F-18 FDG carotid PET/CT. The mean standardized uptake values (SUV), namely target to background ratio (TBR) on 180 minutes delayed F-18 FDG carotid PET/CT images were compared with levels of serum inflammatory markers and lipid profiles, and in terms of the presence of carotid plaque on carotid US.
RESULTS: 180 minutes TBR of carotid arterial wall at echolucent plaque, calcified plaque, and no plaque were 1.40 ± 0.05, 1.23 ± 0.03, 1.17 ± 0.03 in both carotid artery. TBR of carotid arterial walls for echolucent plaque were significantly larger than TBR for calcified, and no plaque respectively at the both side of carotid artery (P < .05). Serum HDL levels were found to be inversely correlated with F-18 FDG uptake at both carotid arteries (r = -0.43, P = .005) on 180 minutes delayed phase images. Also serum hs-CRP levels were found to be correlated with F-18 FDG TBR values of right carotid arteries (r = 0.41, P = .04).
CONCLUSIONS: Our results show that F-18 FDG carotid PET/CT can depict metabolically active atherosclerotic plaques, and suggest that F-18 FDG carotid PET/CT can be used as a noninvasive imaging modality for functional evaluation of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21279492     DOI: 10.1007/s12350-011-9338-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  17 in total

1.  Risk for transient ischemic attacks is mainly determined by intima-media thickness and carotid plaque echogenicity.

Authors:  Andreas Kalogeropoulos; George Terzis; Athina Chrysanthopoulou; George Hahalis; Dimitrios Siablis; Dimitrios Alexopoulos
Journal:  Atherosclerosis       Date:  2006-06-13       Impact factor: 5.162

2.  Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.

Authors:  P M Ridker; N Rifai; M Clearfield; J R Downs; S E Weis; J S Miles; A M Gotto
Journal:  N Engl J Med       Date:  2001-06-28       Impact factor: 91.245

3.  Reproducibility of ultrasound assessment of carotid plaque occurrence, thickness, and morphology. The Tromsø Study.

Authors:  O Joakimsen; K H Bønaa; E Stensland-Bugge
Journal:  Stroke       Date:  1997-11       Impact factor: 7.914

4.  Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging.

Authors:  John R Davies; James H F Rudd; Tim D Fryer; Martin J Graves; John C Clark; Peter J Kirkpatrick; Jonathan H Gillard; Elizabeth A Warburton; Peter L Weissberg
Journal:  Stroke       Date:  2005-11-10       Impact factor: 7.914

5.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events.

Authors:  Paul M Ridker; Nader Rifai; Lynda Rose; Julie E Buring; Nancy R Cook
Journal:  N Engl J Med       Date:  2002-11-14       Impact factor: 91.245

6.  Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG).

Authors:  R J Lederman; R R Raylman; S J Fisher; P V Kison; H San; E G Nabel; R L Wahl
Journal:  Nucl Med Commun       Date:  2001-07       Impact factor: 1.690

7.  Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography.

Authors:  Ahmed Tawakol; Raymond Q Migrino; Udo Hoffmann; Suhny Abbara; Stuart Houser; Henry Gewirtz; James E Muller; Thomas J Brady; Alan J Fischman
Journal:  J Nucl Cardiol       Date:  2005 May-Jun       Impact factor: 5.952

8.  Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis.

Authors:  Mitsuaki Tatsumi; Christian Cohade; Yuji Nakamoto; Richard L Wahl
Journal:  Radiology       Date:  2003-10-30       Impact factor: 11.105

9.  Carotid Intima-Media Thickness, Not Carotid Plaque, is Associated With Large Territory Cerebral Infarction in Patients With Ischemic Stroke.

Authors:  Hyun Ju Yoon; Myung Ho Jeong; Kye Hun Kim; Younggeun Ahn; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang; Jang Ho Bae
Journal:  Korean Circ J       Date:  2010-06-29       Impact factor: 3.243

10.  Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome.

Authors:  Nobuhiro Tahara; Hisashi Kai; Sho-ichi Yamagishi; Minori Mizoguchi; Hiroyuki Nakaura; Masatoshi Ishibashi; Hayato Kaida; Kenkichi Baba; Naofumi Hayabuchi; Tsutomu Imaizumi
Journal:  J Am Coll Cardiol       Date:  2007-03-26       Impact factor: 24.094

View more
  4 in total

Review 1.  Molecular imaging in atherosclerosis: FDG PET.

Authors:  David Rosenbaum; Antoine Millon; Zahi A Fayad
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

2.  Bioenergetic profiles diverge during macrophage polarization: implications for the interpretation of 18F-FDG PET imaging of atherosclerosis.

Authors:  Sina Tavakoli; Debora Zamora; Sarah Ullevig; Reto Asmis
Journal:  J Nucl Med       Date:  2013-07-25       Impact factor: 10.057

Review 3.  Is Carotid Artery Ultrasound Still Useful Method for Evaluation of Atherosclerosis?

Authors:  Gee-Hee Kim; Ho-Joong Youn
Journal:  Korean Circ J       Date:  2016-11-24       Impact factor: 3.243

Review 4.  Imaging atherosclerosis with hybrid [18F]fluorodeoxyglucose positron emission tomography/computed tomography imaging: what Leonardo da Vinci could not see.

Authors:  Myra S Cocker; Brian Mc Ardle; J David Spence; Cheemun Lum; Robert R Hammond; Deidre C Ongaro; Matthew A McDonald; Robert A Dekemp; Jean-Claude Tardif; Rob S B Beanlands
Journal:  J Nucl Cardiol       Date:  2012-12       Impact factor: 5.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.